Vaccines against bluetongue in Europe

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 31, Issue 2-3, 2008, Pages 101-120

  Savini, Giovanni ^a   MacLachlan, N James ^b   Sanchez Vizcaino, Jose Manuel ^c   Zientara, Stéphan ^d  

^a ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELL ABRUZZO E DEL MOLISE G CAPORALE   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d Healthy Pigs Production and Experimentation Section   (France)

Author keywords

Arbovirus; Bluetongue; Orbivirus; Vaccines

Indexed keywords

INACTIVATED VACCINE; LIVE VACCINE; RECOMBINANT VACCINE; VIRUS VACCINE;

ANIMAL LAMENESS; ARTICLE; BLUETONGUE ORBIVIRUS; BOVIDS; CATTLE; CLINICAL FEATURE; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; ENDEMIC DISEASE; FACE EDEMA; FEVER; GEOGRAPHIC DISTRIBUTION; IMMUNITY; IMMUNOGENICITY; ITALY; LACTATION; MILK PRODUCTION; NONHUMAN; POLICY; POPULATION MIGRATION; PORTUGAL; REPEATED DRUG DOSE; SEROTYPE; SHEEP; SHEEP DISEASE; SOUTH AFRICA; SOUTHERN EUROPE; SPAIN; VACCINATION; VETERINARY ABORTION; VIREMIA; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; BLUETONGUE; BLUETONGUE VIRUS; CATTLE; EUROPE; QUALITY CONTROL; SHEEP; VACCINES, ATTENUATED; VACCINES, INACTIVATED; VACCINES, SYNTHETIC; VIRAL VACCINES;

ANIMALIA; ARBOVIRUS; BLUETONGUE VIRUS; BLUETONGUE VIRUS 2; BOS; HEXAPODA; ORBIVIRUS; OVIS ARIES;

EID: 39849091180     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2007.07.006     Document Type: Article

References (63)

1. Verwoerd D., and Erasmus B.J. Bluetongue. In: Coetzer J.A., and Tustin R.C. (Eds). Infectious diseases of livestock. 2nd ed. (2004), Oxford University Press, Cape Town 1201-1220
2. Gibbs E.P., and Greiner E.C. The epidemiology of bluetongue. Comp Immunol Microbiol Infect Dis 17 (1994) 197-206
3. Tabachnick W.J. Culicoides and the global epidemiology of bluetongue virus infection. Vet Ital 40 (2004) 145-150
4. Toussaint J.F., Vandenbussche F., Mast J., De Meester L., Goris N., Van Dessel W., et al. Bluetongue in northern Europe. Vet Rec 2 (2006) 327
5. Mertens P.P., Diprose J., Maan S., Singh K.P., Attoui H., and Samuel A.R. Bluetongue virus replication, molecular and structural biology. Vet Ital 40 (2004) 426-437
6. Bonneau K.R., Zhang N., Zhu J., Zhang F., Li Z., Zhang K., et al. Sequence comparison of the L2 and S10 genes of bluetongue viruses from the United States and the People's Republic of China. Virus Res 61 (1999) 153-160
7. Pritchard L.I., Sendow I., Lunt R., Hassan S.H., Kattenbelt J., Gould A.R., et al. Genetic diversity of bluetongue viruses in south east Asia. Virus Res 101 (2004) 193-201
8. Bonneau K.R., and MacLachlan N.J. Genetic diversification of field strains for bluetongue virus. Vet Ital 40 (2004) 446-447
9. Bonneau K.R., Mullens B.A., and MacLachlan N.J. Occurrence of genetic drift and founder effect during quasispecies evolution of the VP2 and NS3/3A genes of bluetongue virus upon passage between sheep and cattle. J Virol 75 (2001) 8298-8305
10. Calistri P., Giovannini A., Conte A., Nannini D., Santucci U., Patta C., et al. Bluetongue in Italy: part I. Vet Ital 40 3 (2004) 243-251
11. OIE World Organisation for Animal Health. Bluetongue in Italy. Dis Inf 13 (2000) 150
12. OIE World Organisation for Animal Health. Bluetongue in Spain: in the Balearic Islands. Dis Inf 13 (2000) 181
13. Zientara S., Sailleau C., Dauphin G., Roquier C., Remond M., Lebreton F., et al. Identification of bluetongue virus serotype 2 (Corsican strain) by reverse-transcriptase PCR reaction analysis of segment 2 of the genome. Vet Rec 150 19 (2002) 598-601
14. Bréard E., Hamblin C., Hammoumi S., Sailleau C., Dauphin G., and Zientara S. The epidemiology and diagnosis of bluetongue with particular reference to Corsica. Res Vet Sci 77 (2004) 1-8
15. MAPA. Review of the situation of bluetongue in Spain since the outbreak of BT 2 in the Balearic Island. MAPA report, 2006.
16. Patta C., Giovannini A., Rolesu S., Nannini D., Savini G., Calistri P., et al. Bluetongue vaccination in Europe: the Italian experience. Vet Ital 40 4 (2004) 601-610
17. MAPA. Report of the efficacy test performed in Spain with different commercially available vaccine against BTV4 in cattle and sheep. MAPA report, 2006.
18. Giovannini A., MacDiarmid S., Calistri P., Conte A., Savini L., Nannini D., et al. The use of risk assessment to decide the control strategy for bluetongue in Italian ruminant populations. J Risk Anal 24 6 (2003) 1737-1753
19. Murray P.K., and Eaton B.T. Vaccine for bluetongue. Aust Vet J 73 (1996) 207-210
20. Boone J.D., Balasuriya U.B., Karaca K., Audonnet J.C., Yao J., He L., et al. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 25 (2007) 672-678
21. Stott J.L., Barber T.L., and Osburn B.I. Immunologic response of sheep to inactivated and virulent bluetongue virus. Am J Vet Res 46 (1985) 1043-1049
22. Di Emidio B., Nicolussi P., Patta C., Ronchi G.F., Monaco F., Savini G., et al. Efficacy and safety studies on an inactivated vaccine against bluetongue virus serotype 2. Vet Ital 40 (2004) 640-644
23. Roy P., Urakawa T., Van Dijk A.A., and Erasmus B.J. Recombinant virus vaccine for bluetongue disease in sheep. J Virol 64 (1990) 1998-2003
24. Roy P., French T., and Erasmus B.J. Protective efficacy of virus-like particles for bluetongue disease. Vaccine 10 (1992) 28-32
25. Roy P., Bishop D.H., LeBlois H., and Erasmus B.J. Long-lasting protection of sheep against bluetongue challenge after vaccination with like-like particles: evidence for homologous and partial heterologous protection. Vaccine 12 (1994) 805-811
26. Roy P. Genetically engineered structure-based vaccine for bluetongue disease. Vet Ital 40 (2004) 594-600
27. Hamers C, Werle-Lapostolle B, Rehbein S, Blanchet M, Mure-Ravaud K, Schumacher C, Hudelet P. Six month efficacy of an inactivated BTV-2 industrial vaccine against a virulent BTV-2 challenge in sheep. In: Proceedings of the ninth international symposium on double-stranded RNA viruses, Cape Town, South Africa, 21-26 October 2006.
28. Savini G, Hamers C, Migliaccio P, Leone A, Hudelet P, Schumacher C, Caporale V. Assessment of efficacy of a bivalent inactivated vaccine against bluetongue virus serotypes 2 and 4 in cattle. In: Proceedings of the 24th world buiatrics congress, Nice, France, 15-19 October 2006.
29. Savini G, Conte A, Di Gennaro A, Leone A, Migliaccio P, Bonfini B, Di Ventura M, Monaco F. Virological and serological responses in cattle following vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4, 9 and 16. In: Proceedings of the ninth international symposium on ds-RNA viruses, Cape Town, South Africa, 21-26 October 2006.
30. Jiménez-Clavero M.A., Agüero M., San Miguel E., Mayoral T., Cruz López M., Ruano M.J., et al. High throughput detection of bluetongue virus by a new real-time on clinical samples from current mediterranean outbreaks. J Vet Diagn Invest 18 (2006) 7-17
31. Hamers C, Hudelet P, Blanchet M, Werle-Lapostolle B, Sailleau C, Bréard E, Zientara S. Efficacy of an inactivated bivalent BTV-2/BTV-4 industrial vaccine against a BTV-2 or BTV-4 virulent challenge in sheep. In: Proceedings of the ninth international symposium on double-stranded RNA viruses, Cape Town, South Africa, 21-26 October 2006.
32. Caporale V, Giovannini A, Patta C, Calistri P, Nannini D, Santucci U. Vaccination in the control strategy of bluetongue in Italy. (Developments in biologicals, vol. 119). Control of infectious animal diseases by vaccination. Basel, Switzerland: S Karger AG; 2004. p. 113-27. [book chapter. conference paper].
33. Dungu B., Gerdes T., and Smit T. The use of vaccination in the control of bluetongue in southern Africa. Vet Ital 40 (2004) 616-622
34. MacLachlan N.J., Osburn B.I., and Stott J.L. Ghalib HW orbivirus infection of the bovine fetus. Prog Clin Biol Res 178 (1985) 79-84
35. Venter G.J., Gerdes G.H., Mellor P.S., and Paweska J.T. Transmission potential of South African Culicoides species for live-attenuated bluetongue virus. Vet Ital 40 (2004) 198-202
36. Savini G., Monaco F., Facchinei A., Pinoni C., Salucci S., Cofini F., et al. Field vaccination of sheep with bivalent modified-live vaccine against bluetongue virus serotypes 2 and: effect on milk production. Vet Ital 40 4 (2004) 627-630
37. Monaco F., De Luca N., Spina P., Morelli D., Liberatore I., Citarella R., et al. Virological and serological response of cattle following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9. Vet Ital 40 4 (2004) 657-660
38. Monaco F., De Luca N., Morelli D., Pisciella M., Palmarini S., Di Giandomenico M., et al. Field vaccination of cattle using a bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9: effect on milk production. Vet Ital 40 4 (2004) 661-663
39. Ferrari G., De Liberato C., Scavia G., Lorenzetti R., Zini M., Farina F., et al. Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy. Prev Vet Med 68 (2005) 10-13
40. Veronesi E., Hamblin C., and Mellor P.S. Live attenuated bluetongue vaccine viruses in Dorset Poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae). Vaccine 23 48/49 (2005) 5501-5509
41. Hammoumi S., Breard E., Sailleau C., Russo P., Grillet C., Cetre-Sossah C., et al. Innocuity and activity of the monovalent bluetongue serotype 2 vaccine. Specific detection of the genome of the vaccine strain by RT-PCR. J Vet Med B50 (2003) 316-321
42. Ronchi G F., Franchi P., Battistini L., and Di Emidio B. Stability study of bluetongue attenuated live vaccine serotype 2 after rehydration. Vet Ital 39 2 (2003) 11-14
43. Gerbier G, Hendrikx, P, Roger F, Zientara S, Biteau-Coroller F, Grillet C, Baldet T, Albina E. Bluetongue control using vaccines: an experience from the mediterranean islands in Europe. In: Proceedings of the third OIE bluetongue international symposium, Taormina, Sicily, 26-29 October 2003.
44. IZSAM, Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise 'G. Caporale'. Safety and potency testing of bluetongue vaccines. Testing of monovalent bluetongue vaccine (serotype 2) for innocuity, potency and reversion to virulence. Contract DG Sanco 00/0127. Final report. Teramo, 2001. 19pp. 〈http://www.east-btnet.izs.it/document_r/research/final_report.pdf〉.
45. IZSAM, Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise 'G. Caporale'. Vaccino e danni vaccinali, 〈http://gis2.izs.it:7777/bluetongue/doc_tec/danni_vacc/vaccini.pdf〉, 2004.
46. Zientara S, Bréard E, Sailleau C. Bluetongue: characterization of virus types by reverse transcription-polymerase chain reaction. In: Vannier P, Espeseth D, editors. New diagnostic technology: applications in animal health and biologics controls. Basel, IABs/Karger series, Developments in biologicals 2006, vol. 126. p.187-96. ISSN: 1424-6074.
47. Monaco F., Cammà C., Serini S., and Savini G. Differentiation between field and vaccine strain of bluetongue virus serotype 16. Vet Microbiol 116 (2006) 45-52
48. Italian Ministry of Health. Nota del 19 gennaio. Bluetongue-provvedimenti ed impiego del vaccino sierotipo 16 nella IV campagna di vaccinazione 2004-2005, 2005. n.1720.
49. Monaco F., Bonfini B., Zaghini M., Antonucci D., and Pini A & Savini G. Vaccination of cattle using monovalent modified-live vaccine against bluetongue virus serotype 2: innocuity, immunogenicity and effect on pregnancy. Vet Ital 40 4 (2004) 671-675
50. Lucifora G., Rossi P., Calistri P., and Giovannini A. Effects of bivalent bluetongue virus serotypes 2 and 9 vaccine on reproductive performance of cattle: a case study in Calabria, Italy. Vet Ital 40 (2004) 654-656
51. Bréard E., Pozzi N., Sailleau C., Catinot V., Durand B., Dumont P., et al. Transient effect of the attenuated bluetongue virus vaccine on the quality of the ram semen. Vet Rec 160 13 (2007) 431-435
52. Caporale V., Di Emidio B., Nicolussi P., Piredda G., Salaris S., De Palmas S., et al. Experimental vaccination of sheep using a bluetongue attenuated live vaccine: a study of the effects on lactation. Vet Ital 39 4 (2003) 5-10
53. Cannas EA, Nicolussi P, Bonelli P, Dore S, Denti G, Marongiu E, Migliaccio P, Savini G. Live modified bluetongue vaccine viruses in Sarda sheep: effects of three different formulations on milk production. In: Proceedings of the 12th international symposium of the world association of veterinary laboratory diagnosticians, Montevideo, Uruguay, 16-19 November 2005.
54. Giovannini A., Conte A., Panichi G., Calistri P., Dessì M., Foddis F., et al. Effects of vaccination against bluetongue on milk production and quality in cattle vaccinated with live-attenuated monovalent type 2 vaccine. Vet Ital 40 4 (2004) 648-653
55. Savini G., Monaco F., Conte A., Migliaccio P., Casaccia C., Salucci S., et al. Virological and serological response of sheep following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9. Vet Ital 40 4 (2004) 631-634
56. Savini G., Tittarelli M., Bonfini B., Zaghini M., Di Ventura M., and Monaco F. Serological response in cattle and sheep following infection or vaccination with bluetongue virus. Vet Ital 40 4 (2004) 645-647
57. Savini G., Monaco F., Citarella R., Calzetta G., Panichi G., Ruiu A., et al. Monovalent modified-live vaccine against bluetongue virus serotype 2: immunity studies in cows. Vet Ital 40 4 (2004) 664-667
58. Savini G., Monaco F., Calistri P., Panichi G., Ruiu A., Leone A., et al. Neutralising antibody response in cattle after vaccination with monovalent modified-live vaccine against bluetongue virus serotype 2. Vet Ital 40 4 (2004) 668-670
59. Savini G, Cannas EA, Bonelli P, Petruzzi M, Fresi S, Dimauro C, Di Gennaro A, Nicolussi P. Live modified bluetongue vaccine viruses in sarda sheep: clinical signs, haematology and chemistry. In: Proceedings of the 12th international symposium of the world association of veterinary laboratory diagnosticians, Montevideo, Uruguay, 16-19 November 2005.
60. OIE. Terrestrial animal health code. 2005 ed. World Animal Health Organization.
61. Giovannini A., Conte A., Calistri P., Di Francesco C., and Caporale V. Risk analysis on the introduction into free territories of vaccinated animals from restricted zones. Vet Ital 40 4 (2004) 697-702
62. Lobato Z.I., Coupar B.E., Gray C.P., Lunt R., and Andrew M.E. Antibody responses and protective immunity to recombinant vaccinia expressed-expressed bluetongue virus antigens. Vet Immunol Immunopathol 59 (1997) 293-309
63. Wade-Evans A.M., Romero C.H., Mellor P., Takamatsu H., Anderson J., Thevasagayam J., et al. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge. Virology 220 (1996) 227-231